Non-Pharmacologic Approaches to Neuropsychiatric Symptoms in Dementia
Non-pharmacologic interventions are the recommended first-line treatment for neuropsychiatric symptoms (NPS) in dementia, endorsed by the American Geriatrics Society, the American Psychiatric Association, and international consensus guidelines. Given the limited FDA-approved pharmacologic agents for NPS and the significant adverse effect burden of psychotropic medications in older adults — including the FDA boxed warning on antipsychotics for increased mortality — behavioral and environmental approaches carry particular importance. Evidence demonstrates that well-implemented non-pharmacologic interventions can reduce agitation, depression, anxiety, and sleep disturbances with effect sizes comparable to or exceeding those of pharmacologic agents, while avoiding the risks of sedation, falls, metabolic syndrome, and cerebrovascular events.
Bottom Line
- First-line status: Non-pharmacologic approaches are the recommended first-line treatment for NPS in all dementias; pharmacologic therapy should supplement — not replace — behavioral interventions
- DICE framework: The Describe, Investigate, Create, Evaluate model provides a systematic approach to identifying triggers, designing individualized interventions, and assessing outcomes
- Caregiver training: Programs such as STAR-C and REACH II produce sustained reductions in NPS and care partner distress through behavioral management techniques
- Music therapy has the strongest evidence among sensory interventions, with meta-analyses showing moderate effect sizes (d ≈ 0.5–0.7) for agitation and anxiety reduction
- Exercise and light therapy address multiple NPS simultaneously while providing circadian, cardiovascular, and neurobiological benefits
- Person-centered care models that tailor interventions to individual biography, preferences, and retained abilities produce more durable behavioral improvements than generic protocols
- Escalation criteria: Add pharmacologic treatment when NPS cause significant distress or safety risk despite adequate non-pharmacologic trials, or when urgent management is required
The DICE Approach
The DICE framework (Describe, Investigate, Create, Evaluate), developed by Kales, Gitlin, and Lyketsos, provides a systematic method for managing NPS by analyzing behavioral triggers rather than reflexively reaching for pharmacologic interventions.
- Describe: Obtain a detailed, objective account of the behavior — what it is, when and where it occurs, how often, who is present, and what precedes and follows it (antecedents and consequences)
- Investigate: Explore potential causes across four domains: patient factors (pain, infections, delirium, sensory deficits, unmet needs), care partner factors (communication style, unrealistic expectations, stress), environmental factors (overstimulation, understimulation, lighting, noise), and dementia-related factors (disease stage, frontal disinhibition, misperceptions)
- Create: Collaborate with the care partner to design a tailored intervention plan that is feasible within their specific circumstances and abilities
- Evaluate: Assess outcomes systematically; if the behavior persists, return to the Investigate step, modify the intervention, and re-evaluate
DICE in Practice: Common Trigger–Intervention Pairs
- Pain → Scheduled analgesics (acetaminophen), repositioning; use PAINAD scale for non-verbal patients
- Overstimulation → Reduce noise, limit visitors, create a calm retreat space
- Unmet toileting needs → Scheduled toileting protocol every 2 hours
- Care resistance during bathing → Towel bath, warm room, same caregiver, calm verbal cues, preferred music
- Boredom/understimulation → Structured activity schedule tailored to retained abilities and past interests
- Medication side effects → Medication reconciliation; discontinue anticholinergics, sedative-hypnotics, or offending agents
- Sundowning → Afternoon bright light exposure, consistent evening routine, avoid caffeine after noon
Environmental Modifications
Patients with moderate-to-severe dementia are highly stimulus-bound — minor environmental changes can provoke agitation, while thoughtfully designed spaces promote calm. Key modifications include:
- Lighting: Bright ambient lighting (2,500–10,000 lux) during daytime supports circadian entrainment; low-level amber nightlights reduce nocturnal agitation without suppressing melatonin
- Noise reduction: Minimize background noise (television, overhead pages); designate quiet zones; use soft familiar music or nature sounds
- Safe wandering paths: Enclosed indoor or garden looping circuits allow safe ambulation, reducing elopement risk while supporting physical activity
- Visual cues: Color-coded hallways, picture signs, and clear sightlines to bathrooms reduce disorientation and frustration
- Door camouflage: Painting exit doors to match walls or using murals reduces exit-seeking behavior without physical restraints
- Hazard removal: Eliminate mirrors that provoke misidentification distress; reduce clutter that creates navigational barriers
Caregiver-Based Interventions
Caregiver training programs are among the most robustly evidence-based non-pharmacologic interventions. They operate on the principle that care partner behavior, communication, and environmental management are modifiable factors that directly influence patient NPS.
STAR-C and REACH II Programs
STAR-C (Staff Training in Assisted Residences – Caregivers) teaches care partners the ABC model (Antecedent–Behavior–Consequence), antecedent modification, and pleasant activity scheduling across 8 sessions. RCTs demonstrate significant reductions in behavioral disturbances, care partner depression, and burden. REACH II (Resources for Enhancing Alzheimer’s Caregiver Health) is a multicomponent NIH-funded intervention addressing safety, social support, emotional well-being, self-care, and problem behavior management through 12 individualized sessions. It significantly improved care partner quality of life and reduced patient behavioral problems, with successful adaptation for Hispanic and Black caregivers.
Core Components of Effective Caregiver Training
- Education: Understanding dementia as the cause of behaviors; adjusting expectations to match the patient’s cognitive stage
- Communication training: Short, simple sentences; one-step commands; calm tone; avoid confrontation or correction; offer choices rather than open-ended questions
- ABC analysis: Systematically identify Antecedents, Behaviors, and Consequences to find modifiable triggers
- Activity scheduling: Structure meaningful, failure-free activities matched to retained abilities and past interests
- Self-care: Address care partner stress, depression, and burnout — care partner well-being directly influences patient NPS
Sensory and Activity-Based Therapies
Music Therapy
Music therapy has the strongest evidence base among sensory interventions. Personalized protocols using music from the patient’s young adult years (ages 18–25) produce larger effect sizes than generic selections. Active music therapy (singing, rhythm instruments) may improve social engagement more than passive listening, though both reduce agitation. Music during care tasks (bathing, dressing) reduces resistance, and during sundowning hours attenuates escalating behaviors. Meta-analyses report moderate effect sizes (Cohen’s d ≈ 0.5–0.7) for agitation reduction. Procedural musical memory and emotional responsiveness to music are preserved well into advanced dementia.
Art Therapy and Reminiscence Therapy
Art-based interventions (painting, drawing, collage) provide nonverbal self-expression with modest benefits for mood and social interaction, particularly valuable for patients with language deficits who retain visuospatial abilities. Reminiscence therapy uses photographs, music, and personal objects to leverage preserved remote autobiographical memory. Systematic reviews show improvements in mood, communication, and care partner–patient relationship quality. Life story books serve as durable tools for ongoing use by care partners and staff.
Exercise Interventions
Physical exercise addresses multiple NPS through neurobiological (neurotrophic factors, monoamine regulation), circadian (improved sleep-wake cycles), and psychological (reduced boredom, improved self-efficacy) mechanisms.
| Exercise Type | NPS Targeted | Evidence |
|---|---|---|
| Aerobic (walking, cycling) | Depression, agitation, sleep, anxiety | 30–45 min, 3–5×/week; effect sizes 0.3–0.6 |
| Resistance training | Apathy, depression, agitation | Supervised 2–3×/week; improves functional mobility alongside NPS |
| Tai chi / yoga | Anxiety, agitation, sleep | Dual benefit of activity and relaxation; adapted programs available |
| Dance therapy | Depression, social withdrawal | Combines activity, music, and social engagement; effective in groups |
| Walking programs | Wandering, agitation, sleep | Channels wandering constructively; outdoor light enhances circadian benefits |
Light Therapy for Circadian Disruption and Sundowning
Sundowning — worsening agitation, confusion, and wandering in late afternoon/evening — affects up to 66% of patients with dementia and is linked to degeneration of the suprachiasmatic nucleus (SCN). Bright light therapy (2,500–10,000 lux) delivered via light boxes or ceiling panels, typically 30–120 minutes in the morning (8:00–10:00 AM), helps consolidate the sleep-wake cycle. Benefits emerge after 2–4 weeks and include improved nighttime sleep duration, reduced nocturnal awakenings, and decreased daytime agitation. Light therapy is generally well tolerated but should be used with caution in patients with retinal disease or photosensitizing medications.
Person-Centered Care Models
Person-centered care, articulated by Tom Kitwood, places the individual’s biography, personality, preferences, and remaining abilities at the center of care planning. Core principles include recognizing personhood regardless of cognitive impairment, using biographical knowledge to inform activities, validating emotions rather than correcting factual errors, and adapting care routines to the patient’s rhythms. Systematic reviews demonstrate reductions in agitation, psychotropic medication use, and physical restraints in residential facilities implementing person-centered models.
When to Escalate to Pharmacologic Treatment
Indications for Pharmacologic Escalation
- Safety risk: Physical aggression, self-harm, or elopement risk that cannot be managed behaviorally
- Severe distress: Marked patient suffering (severe anxiety, paranoid delusions, frightening hallucinations) despite adequate non-pharmacologic intervention
- Care partner crisis: Imminent risk of care breakdown, placement, or care partner health deterioration
- Persistent symptoms: Target behaviors persist despite systematic DICE implementation over 2–4 weeks
- Acute psychosis: New-onset delusions or hallucinations causing significant behavioral disturbance
- Severe sleep disruption: Persistent nocturnal agitation or sleep-wake reversal unresponsive to light therapy and sleep hygiene
Even when pharmacologic treatment is initiated, non-pharmacologic interventions should continue. Combined approaches are more effective than either modality alone, and ongoing behavioral management may permit lower medication doses and earlier tapering.
Evidence Comparison: Non-Pharmacologic vs. Pharmacologic Efficacy
| Intervention | Target NPS | Effect Size (d) | Adverse Effects |
|---|---|---|---|
| Caregiver training (STAR-C, REACH II) | Agitation, depression | 0.3–0.5 | None |
| Music therapy | Agitation, anxiety | 0.5–0.7 | None |
| Exercise programs | Depression, agitation, sleep | 0.3–0.6 | Falls (minimal with supervision) |
| Light therapy | Sleep, sundowning | 0.3–0.5 | Minimal (eye strain) |
| SSRIs (citalopram, escitalopram) | Agitation, depression | 0.3–0.5 | GI effects, QTc prolongation, worsening apathy |
| Atypical antipsychotics | Agitation, psychosis | 0.2–0.4 | Sedation, metabolic syndrome, EPS, cerebrovascular events, mortality (FDA boxed warning) |
The number needed to treat (NNT) for antipsychotics in dementia-related agitation is 5–14, with a number needed to harm (NNH) of 9–25 for serious adverse effects. Non-pharmacologic interventions achieve comparable NNTs without these harms.
Multicomponent Intervention Programs
The most effective approaches combine multiple strategies. Key evidence-based programs include:
| Program | Components | Key Outcomes |
|---|---|---|
| REACH II | Caregiver education, behavioral skills, stress management, social support, safety planning | Reduced care partner depression/burden; decreased patient NPS; effective across racial/ethnic groups |
| TAP (Tailored Activity Program) | OT assessment of abilities; individualized activity prescription; care partner training | Reduced agitation; increased engagement; reduced care partner burden |
| WHELD | Person-centered care training, social interaction, antipsychotic review, pleasant activities | Improved quality of life; reduced agitation and antipsychotic use in care homes |
| Dementia Care Mapping | Systematic observation, staff feedback, action planning, person-centered training | Reduced agitation; improved care quality; reduced psychotropic use |
Implementation Challenges
- Resource intensity: Effective programs require trained staff, dedicated time, and ongoing supervision — often lacking in understaffed facilities
- Care partner burnout: Overburdened family caregivers may lack capacity to sustain complex behavioral protocols
- Training fidelity: Outcomes depend on consistent, high-quality intervention delivery
- Insurance coverage: Many non-pharmacologic services have variable reimbursement
- Individualization required: Generic approaches are less effective; ongoing assessment and adaptation to the individual patient is essential
References
- Marshall GA. Neuropsychiatric symptoms in dementia. Continuum (Minneap Minn). 2024;30(6, Dementia):1744-1760.
- Kales HC, Gitlin LN, Lyketsos CG. Assessment and management of behavioral and psychological symptoms of dementia. BMJ. 2015;350:h369.
- Livingston G, Huntley J, Sommerlad A, et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet. 2020;396(10248):413-446.
- Gitlin LN, Kales HC, Lyketsos CG. Nonpharmacologic management of behavioral symptoms in dementia. JAMA. 2012;308(19):2020-2029.
- Belle SH, Burgio L, Burns R, et al. Enhancing the quality of life of dementia caregivers from different ethnic or racial groups: a randomized, controlled trial. Ann Intern Med. 2006;145(10):727-738.
- Teri L, McKenzie G, LaFazia D, et al. Improving dementia care in assisted living residences: STAR-C outcomes. Gerontologist. 2012;52(5):640-648.
- van der Steen JT, Smaling HJ, van der Wouden JC, et al. Music-based therapeutic interventions for people with dementia. Cochrane Database Syst Rev. 2018;7(7):CD003477.
- Livingston G, Kelly L, Lewis-Holmes E, et al. Non-pharmacological interventions for agitation in dementia: systematic review of randomised controlled trials. Br J Psychiatry. 2014;205(6):436-442.
- Forbes D, Blake CM, Thiessen EJ, et al. Light therapy for improving cognition, activities of daily living, sleep, challenging behaviour, and psychiatric disturbances in dementia. Cochrane Database Syst Rev. 2014;2:CD003946.
- Figueiro MG, Plitnick B, Roohan C, et al. Effects of a tailored lighting intervention on sleep quality, rest-activity, mood, and behavior in older adults with Alzheimer disease. J Clin Sleep Med. 2019;15(12):1757-1767.
- Brodaty H, Arasaratnam C. Meta-analysis of nonpharmacological interventions for neuropsychiatric symptoms of dementia. Am J Psychiatry. 2012;169(9):946-953.
- Gitlin LN, Winter L, Burke J, et al. Tailored activities to manage neuropsychiatric behaviors in persons with dementia and reduce caregiver burden. Am J Geriatr Psychiatry. 2008;16(3):229-239.
- Ballard C, Corbett A, Orrell M, et al. Impact of person-centred care training on quality of life, agitation, and antipsychotic use in people with dementia (WHELD). PLoS Med. 2018;15(2):e1002500.
- Chenoweth L, King MT, Jeon YH, et al. CADRES of person-centred care, dementia-care mapping, and usual care in dementia: a cluster-randomised trial. Lancet Neurol. 2009;8(4):317-325.
- Polsinelli AJ. Care partner burden and support services in dementia. Continuum (Minneap Minn). 2024;30(6, Dementia):1845-1862.
- Porsteinsson AP, Drye LT, Pollock BG, et al. Effect of citalopram on agitation in Alzheimer disease: the CitAD randomized clinical trial. JAMA. 2014;311(7):682-691.